Amphetamine Completed Phase 1 Trials for Healthy Volunteers Other

IndicationsStatusPurposePhase
CompletedOther1
clinicaltrials.gov IdentifierTitleDrugs
NCT02959892A Single-Dose Positron Emission Tomography (PET) Study to Determine the Effect of TAK-041 on Amphetamine-Induced Dopamine Release in the Central Nervous System (CNS)